173 related articles for article (PubMed ID: 33930608)
1. Methylation status of ADAM12 promoter are associated with its expression levels in colorectal cancer.
Wang Y; Zhang J; Cao H; Han F; Zhang H; Xu E
Pathol Res Pract; 2021 May; 221():153449. PubMed ID: 33930608
[TBL] [Abstract][Full Text] [Related]
2. The expression of ADAMTS14 is regulated by promoter DNA methylation and is associated with poor prognosis in colorectal cancer.
Wang Y; Zhou J; Zhang J; Cao H; Han F; Zhang H; Xu E
Exp Cell Res; 2022 Jan; 410(1):112953. PubMed ID: 34856162
[TBL] [Abstract][Full Text] [Related]
3. Alcohol dehydrogenase, iron containing, 1 promoter hypermethylation associated with colorectal cancer differentiation.
Tae CH; Ryu KJ; Kim SH; Kim HC; Chun HK; Min BH; Chang DK; Rhee PL; Kim JJ; Rhee JC; Kim YH
BMC Cancer; 2013 Mar; 13():142. PubMed ID: 23517143
[TBL] [Abstract][Full Text] [Related]
4. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
5. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
6. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
7. Demethylation by 5-aza-2'-deoxycytidine in colorectal cancer cells targets genomic DNA whilst promoter CpG island methylation persists.
Mossman D; Kim KT; Scott RJ
BMC Cancer; 2010 Jul; 10():366. PubMed ID: 20618997
[TBL] [Abstract][Full Text] [Related]
8. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of membrane type 3 matrix metalloproteinase is associated with cell migration in colorectal adenocarcinoma.
Moon JW; Choi JH; Lee SK; Lee YW; Lee JO; Kim N; Lee HJ; Seo JS; Kim J; Kim HS; Kim GJ; Park SH
Cancer Genet; 2015 May; 208(5):261-70. PubMed ID: 26002729
[TBL] [Abstract][Full Text] [Related]
12. Promoter Hypermethylation of the Eyes Absent 4 Gene is a Tumor-Specific Epigenetic Biomarker in Iranian Colorectal Cancer Patients.
Barati Bagerabad M; Tavakolian S; Abbaszadegan MR; Kerachian MA
Acta Med Iran; 2018 Jan; 56(1):21-27. PubMed ID: 29436791
[TBL] [Abstract][Full Text] [Related]
13. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
[TBL] [Abstract][Full Text] [Related]
14. Expression of BMP6 is associated with its methylation status in colorectal cancer tissue but lacks prognostic significance.
Sangplod P; Kanngurn S; Boonpipattanapong T; Ruangrat P; Sangkhathat S
Asian Pac J Cancer Prev; 2014; 15(17):7091-5. PubMed ID: 25227796
[TBL] [Abstract][Full Text] [Related]
15. Aberrant DNA methylation of ADAMTS16 in colorectal and other epithelial cancers.
Kordowski F; Kolarova J; Schafmayer C; Buch S; Goldmann T; Marwitz S; Kugler C; Scheufele S; Gassling V; Németh CG; Brosch M; Hampe J; Lucius R; Röder C; Kalthoff H; Siebert R; Ammerpohl O; Reiss K
BMC Cancer; 2018 Aug; 18(1):796. PubMed ID: 30081852
[TBL] [Abstract][Full Text] [Related]
16. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Methylation of Tumour Suppressor Gene ADAM12 in Chronic Lympocytic Leukemia Patients: Application of Methylation Specific-PCR Technique.
Mohamad A; Hassan R; Husin A; Johan MF; Sulong S
Asian Pac J Cancer Prev; 2021 Jan; 22(1):85-91. PubMed ID: 33507683
[TBL] [Abstract][Full Text] [Related]
18. Methylation of the KEAP1 gene promoter region in human colorectal cancer.
Hanada N; Takahata T; Zhou Q; Ye X; Sun R; Itoh J; Ishiguro A; Kijima H; Mimura J; Itoh K; Fukuda S; Saijo Y
BMC Cancer; 2012 Feb; 12():66. PubMed ID: 22325485
[TBL] [Abstract][Full Text] [Related]
19. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
20. ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer.
Mendaza S; Ulazia-Garmendia A; Monreal-Santesteban I; Córdoba A; Azúa YR; Aguiar B; Beloqui R; Armendáriz P; Arriola M; Martín-Sánchez E; Guerrero-Setas D
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]